Venlafaxine Hydrochloride
Product Images NDC 68151-3659

6 FDA label images from Carilion Materials Management · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68151-3659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 3659)

Label Image (68151 3659)
Label detail for Venlafaxine Hydrochloride extended-release 37.5 mg capsule with manufacturer Greenstone. The label shows lot number M59096, expiration date 08/16, and a product code bar with number 0000003659, indicating it is prescription-only.*
FDA Label Image

Figure 1 (Venlafaxine 01)

Figure 1 (Venlafaxine 01)
A chart displaying the pharmacokinetic (PK) fold change with 90% confidence intervals for venlafaxine and its analyte when administered with various interacting drugs, including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis shows the change relative to a reference value, while the chart includes clinical recommendations such as dose adjustments and cautions for certain interactions.*
FDA Label Image

Figure 2 (Venlafaxine 02)

Figure 2 (Venlafaxine 02)
A dot plot chart showing pharmacokinetic fold changes (Cmax and AUC) for various interacting drugs with Venlafaxine Hydrochloride. The chart compares the change relative to a reference value and includes recommendations for each interacting drug, such as avoiding concomitant use or no dose adjustment needed.*
FDA Label Image

Figure 3 (Venlafaxine 03)

Figure 3 (Venlafaxine 03)
A scatter plot chart showing fold change and 90% confidence intervals for pharmacokinetic variables (Cmax, AUC, ODV) of venlafaxine in different special populations including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender. Recommendations for dose adjustments are listed alongside for each group.*
FDA Label Image

Chemical Structure (Venlafaxine 04)

Chemical Structure (Venlafaxine 04)
Chemical structure of venlafaxine hydrochloride, showing its molecular framework including aromatic ring, functional groups, and hydrochloride salt representation.*
FDA Label Image

Logo (Venlafaxine 05)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.